Latest News

MRC DPFS to Fund Consortium Wave II Research

The Consortium has been awarded a 1.2 million to fund the development of our Wave II Lentiviral Research Programme. This grant has been awarded by the MRC DPFS Scheme. The aim of this research is to use a modified virus to replace the defective CFTR gene in the human airways.

5 years ago

 

 

Horspath Village CF Trust Quiz

In what has become the highlight of the Oxford social Calendar the GeneMed team attended the Horspath Village CF Trust Quiz. Seriously hampered by the lack of questions on gene expression analysis, MHRA regulations, Bioinformatics and things you can buy from Life Technologies the team did well to make it into the top half by the end. However, plaudits were received for the outstanding appearance and attire of the team.

5 years ago

 

 

James Peckham Rose of Hope Charity Cycle Ride

James Peckham from Southampton cycled 500 miles from London to Edinburgh via Oxford in one week to raise money for the Cystic Fibrosis Trust Gene Therapy appeal. James visited each of the UK CF Gene Therapy Consortium's Research Centres on route to deliver a Rose of Hope.

5 years ago

 

 

Rosie Barnes Awarded OBE

In the Queen's Birthday Honours List, Rosie Barnes, former Chief Executive of the CF Trust was awarded an OBE for her services to healthcare.

5 years ago

 

 

Consortium Wins Two MFIA Awards

The Consortium was nominated for two awards at the Medical Futures Innovation Awards 2011. At the awards ceremony held in London, our Lentiviral Research Programme was recognised twice by the judging panel. We won Best Therapeutic Innovation in the Respiratory category and also walked off with the highly prestigious MRC Translational Research Award.

5 years ago

 

 

New Publication Describes Consortium Mixing Device

A novel mixing device for the reproducible generation of nonviral gene therapy formulations, Davies et al., Biotechniques, 49, 666-668. A new publication by Davies et al, describes the development of a new mixing device to be used in out clinical trial programme.

6 years ago

 

 

HGP is 10: the gene therapy challenge.

As we approach the 10th anniversary of the publishing of the draft human genome, Dr Deborah Gill spoke to the Oxford Science Blog about Cystic Fibrosis.

6 years ago

 

 

Interview with Dr Deborah Gill in Oxford University Blueprint Magazine

Dr Deborah Gill was interviewed about the Consortium's work for this month's issue of Oxford University's Blueprint Magazine.

7 years ago

 

 

Consortium Featured on BBC Radio 4 Trials for Life

The work of the Consortium and our ongoing clinical trial was featured on BBC Radio 4, Trials for Life.

7 years ago

 

 

Consortium Featured in Observer Magazine

The work of the Consortium was featured in an Observer Magazine article by Robin McKie.

8 years ago

 

 

VGXi Sign Deal to Manufacture DNA for the Consortium

VGXi Pharmaceuticals sign a multi-year production agreement with the United Kingdom Cystic Fibrosis Gene Therapy Consortium.

8 years ago

 

 

Ian Pringle Wins Outstanding Young Scientist Award at BSGT

Consortium Scientist Dr Ian Pringle won the Lez Fairbairn award for the Outstanding Young Scientist at the BSGT Conference in London

11 years ago

 

 

 

Human airway liquid interface cultures transduced with a lentivirus expressing Luciferase.

 

Pellets of DNA following precipitation.

 

Large scale lentivirus production in suspension culture.

 

A CFTR Western blot, to confirm protein production in cell culture.